Michael R. Hayden
United States of America
Dr. Michael Hayden joined Teva as president of Global R&D and chief scientific officer in May 2012. He is also the Killam Professor of Medical Genetics at the University of British Columbia and Canada Research Chair in Human Genetics and Molecular Medicine. In addition, he is the founder and senior scientist of the Centre for Molecular Medicine and Therapeutics at the University of British Columbia.Prior to joining Teva, Dr. Hayden founded three biotechnology companies – NeuroVir, Aspreva Pharmaceuticals, and Xenon Pharmaceuticals Inc. – and served as chief scientific officer of Xenon from 2000 to 2012. He also served as a director of Med Biogene Inc. (2010 – 2011). Hayden is the recipient of numerous honors and awards, including the Canada Gairdner Wightman Award in 2011, the Order of Canada Award (2010), which is the highest honor that Canada can give its citizens for exceptional achievement, and the Distinguished Scientist Award of the Canadian Society of Clinical Investigation (1998). In 2008 Dr. Hayden was named Canada’s Health Researcher of the Year.
Diagnostic Techniques and Biomedical Analysis Biomedical Data Mining